IMO thank you, this is helpful and is exciting when you see some of the results where there was substantial improvement with Leronlimab. Adding to that, if there is the possibility that the ones that provided less than placebo or equal benefit might be better with LL makes that even more encouraging.
Definitely seems like something CYDY can explore later down the road IMO.
(2)
(0)
CytoDyn Inc (CYDY) Stock Research Links
The fault-finder will find faults even in paradise. -Henry David Thoreau
Alm. Brand A/S Share Buyback Program OverviewAlm. Brand A/S has implemented a comprehensive share buyback program, highlighting the company's commitment to enhancing shareholder value. This initiative, as part of a broader strategy, allows the company to repurchase its shares in the market, thereby providing additional returns to its investors.Recent Transactions and Financial ImpactFrom October 21 to October 25, the company executed several significant share buyback ... Continue Reading
Digitalist Group Secures Significant FundingDigitalist Group Plc has recently reached an agreement with Turret Oy Ab for a loan of EUR 1,000,000. This financing initiative aims to bolster the Company's working capital, allowing Digitalist Group to continue its growth trajectory and operational developments.Loan Details and StructureThis loan is set to be withdrawn in installments, providing flexibility that aligns with the Company's operational needs. The final withdr... Continue Reading
Alm. Brand Group's Upcoming Q3 2024 Results
Alm. Brand Group is getting ready for a significant announcement regarding its Q3 2024 results. Investors and analysts are eagerly anticipating the figures, which will be revealed on November 7 at 8:00 CET.
Insight Into Consensus Estimates
Prior to the results announcement, Alm. Brand Group has published consensus estimates. This information is vital as it provides a snapshot of market expectations and performance benchmarks... Continue Reading
Zoomcar's Approach to Financial TransparencyZoomcar Holdings, Inc. (NASDAQ: ZCAR), the groundbreaking marketplace for self-drive car sharing, is preparing to unveil its financial and operating results for the second quarter. This announcement is expected to occur before the markets open. Investors and interested parties are encouraged to tune in and learn more about the company's performance.Live Webinar Discussion ScheduledManagement at Zoomcar will host a live webin... Continue Reading
NaoTrac to Shine at MEDICA 2024NaoTrac, a state-of-the-art autonomous surgical navigation robot developed by Brain Navi Biotechnology, will make a significant impact at MEDICA 2024, the largest medical trade fair globally. This exciting event is taking place in Düsseldorf, providing a unique platform for showcasing advanced medical technologies. NaoTrac aims to revolutionize the field of neurosurgery with its cutting-edge machine vision technology that greatly enhances navigation pre... Continue Reading
Ottimo Pharma Welcomes New Leadership
Ottimo Pharma, a dynamic biotechnology firm, is thrilled to announce the onboarding of highly esteemed professionals to its leadership team. This move signals an exciting phase for the company, known for its innovative approaches in developing groundbreaking cancer therapies.
Meet the New Leadership Team
David Epstein Takes the Helm
David Epstein joins Ottimo Pharma as Chair and Chief Executive Officer. With an impressive... Continue Reading
Cerillion Empowers Digital Engagement with New Self-Service Module
Cerillion (AIM: CER), a prominent provider of BSS/OSS-as-a-Service solutions for the telecom sector, has unveiled the general availability of its latest version, Cerillion 24.2. This release includes a new composable Self Service module, designed to enhance digital engagement and streamline customer interactions.
Transforming Customer Interactions
The new Self Service module is built on a next-generati... Continue Reading
Biban24: A Gateway for Entrepreneurs and SMEsBiban24 is an exciting initiative that invites entrepreneurs and SME leaders from around the globe to come together and thrive. This flagship forum is more than just an event; it is a vibrant ecosystem where opportunities are limitless.The Essence of Biban24Standing as a major event in Saudi Arabia, Biban24 consolidates its role as a leading destination for business innovation, bringing together visionaries, innovators, and... Continue Reading
Zoomcar's Upcoming Financial Results Announcement
Zoomcar Holdings, Inc. (NASDAQ: ZCAR) is set to unveil its financial and operating results for the second quarter, which ended September 30, 2024. This news comes as the Company continues to solidify its position as a leading marketplace for self-drive car sharing.
Details of the Financial Results Release
The announcement is scheduled for November 14, 2024, before the markets open. Investors can expect the detailed fin... Continue Reading
European Share Markets Show Cautious OptimismEuropean shares experienced a moderate increase as investors braced for an exciting week filled with key economic data releases and anticipated earnings from major U.S. companies. This anticipation reflects a broader sentiment in the market as traders assess upcoming reports that could shape financial trends.STOXX Index Sees GrowthThe pan-European STOXX 600 index saw a rise of 0.2%, climbing to 519.80 points as the markets ... Continue Reading